We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$21.9B
AUM Growth
+$870M
Cap. Flow
-$433M
Cap. Flow %
-1.98%
Top 10 Hldgs %
43.67%
Holding
276
New
31
Increased
44
Reduced
103
Closed
5

Top Sells

Rank Stock Value
1
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$43.3M
2
TGT icon
Target
TGT
+$39.5M
3
XOM icon
ExxonMobil
XOM
+$32.7M
4
AAPL icon
Apple
AAPL
+$31.4M
5
HSBC icon
HSBC
HSBC
+$27.6M

Sector Composition

Rank Sector Weight
1 Consumer Staples 27.8%
2 Energy 25.94%
3 Financials 12.03%
4 Healthcare 10.86%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCX icon
51
Freeport-McMoran
FCX
$86.2B
$129M 0.59%
3,516,949
-273,150
-7% -$9.35M
CB icon
52
Chubb
CB
$140B
$126M 0.58%
1,216,840
+61,714
+5% +$6.32M
MHFI
53
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$126M 0.58%
1,519,716
-80,361
-5% -$6.33M
TWC
54
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$125M 0.57%
845,112
-52,742
-6% -$7.4M
STT icon
55
State Street
STT
$48.4B
$124M 0.57%
1,839,810
+43,982
+2% +$2.89M
UNP icon
56
Union Pacific
UNP
$174B
$115M 0.52%
1,148,342
+19,866
+2% +$1.93M
HSBC icon
57
HSBC
HSBC
$352B
$114M 0.52%
2,611,142
-618,656
-19% -$27.6M
GILD icon
58
Gilead Sciences
GILD
$165B
$110M 0.5%
1,316,924
+218,618
+20% +$17M
NVS icon
59
Novartis
NVS
$302B
$102M 0.47%
1,253,416
+19,227
+2% +$1.51M
APD icon
60
Air Products & Chemicals
APD
$65.5B
$99.4M 0.45%
834,649
-29,423
-3% -$3.28M
WFC icon
61
Wells Fargo
WFC
$254B
$87.7M 0.4%
1,666,915
-24,264
-1% -$1.22M
ORCL icon
62
Oracle
ORCL
$339B
$78.3M 0.36%
1,929,906
-39,367
-2% -$1.62M
BUD icon
63
AB InBev
BUD
$164B
$57.2M 0.26%
+497,729
New +$54.7M
K
64
DELISTED
Kellanova
K
$55.8M 0.26%
904,167
-11,002
-1% -$689K
EOG icon
65
EOG Resources
EOG
$77.7B
$54.4M 0.25%
465,556
-114,962
-20% -$12.1M
BRK.A icon
66
Berkshire Hathaway Class A
BRK.A
$1.1T
$53.6M 0.25%
282
-6
-2% -$1.14M
WFM
67
DELISTED
Whole Foods Market Inc
WFM
$44.9M 0.21%
1,161,473
-45,825
-4% -$2M
TRLA
68
DELISTED
TRULIA INC (DEL)
TRLA
$42M 0.19%
885,408
HD icon
69
Home Depot
HD
$337B
$37.3M 0.17%
461,113
-38,579
-8% -$3.04M
KMPR icon
70
Kemper
KMPR
$1.81B
$37.3M 0.17%
1,011,238
-25,850
-2% -$956K
IMO icon
71
Imperial Oil
IMO
$62.3B
$27.1M 0.12%
514,047
+35,025
+7% +$1.72M
XLNX
72
DELISTED
Xilinx Inc
XLNX
$26.4M 0.12%
554,217
-2,763
-0.5% -$133K
ESRX
73
DELISTED
Express Scripts Holding Company
ESRX
$26.4M 0.12%
380,174
-43
-0% -$3.03K
ASML icon
74
ASML
ASML
$596B
$25.9M 0.12%
275,859
-305
-0.1% -$26.3K
PFE icon
75
Pfizer
PFE
$143B
$18.6M 0.08%
658,734
+12,348
+2% +$352K

Similar funds

Fayez Sarofim & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Fayez Sarofim & Co held 276 positions worth $21.9B, up 4.1% from $21B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Fayez Sarofim & Co's Q2 2014 filing shows 31 new, 44 increased, 103 reduced and 5 closed positions. Its largest new stake was AB InBev: 497,729 shares worth $57.2M. The largest sale was Royal Dutch Shell PLC ADS Class A, an estimated $43.3M.

By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 28% a quarter earlier, followed by Energy and Financials.

  • Fayez Sarofim & Co's largest Q2 2014 buy was AB InBev: 497,729 shares worth $57.2M.
  • Fayez Sarofim & Co added most to Twenty-First Century Fox, Inc. Class A in Q2 2014, an estimated $25.7M increase.
  • Fayez Sarofim & Co's biggest Q2 2014 reduction was Royal Dutch Shell PLC ADS Class A, cutting an estimated $43.3M.
  • Fayez Sarofim & Co fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $510K.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $21.9B portfolio in Q2 2014.
  • Fayez Sarofim & Co opened 31 new positions and closed 5 in Q2 2014.
  • Fayez Sarofim & Co's portfolio value rose 4.1% quarter-over-quarter to $21.9B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2014, filed 14 Aug 2014.